未登录

S

Sheng Tang

Nanjing Medical University

H指数:18

被引数:876

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Serum sortilin as a potential diagnostic and therapeutic target for cardiovascular calcification in uremic patients: A single-center prospective and observational study

血清Sortilin作为尿毒症患者心血管钙化的潜在诊断和治疗靶点：一项单中心前瞻性观察性研究

Clinica Chimica Acta

IF2.9

2025-08-240

PRE

Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/ c-Met inhibitors for the treatment of NSCLC

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-01-015

PRE

Design, synthesis and biological evaluation of 4-(4-aminophenoxy) picolinamide derivatives as potential antitumor agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-09-019

PRE

Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-07-014

OAAI

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-11-0116

OAAI

Capture and Identification of Dual Specificity Mitogen-Activated Protein Kinase Kinase 7 as a Direct Proteomic Target of Berberine to Affect the c-JunN-Terminal Kinase Pathway

IF9.2

2022-05-0112

OA

Synthesis, bioevaluation and molecular dynamics of pyrrolo-pyridine benzamide derivatives as potential antitumor agents in vitro and in vivo

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-04-0114

PRE

Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations

IF4.6

2022-02-2820

OAAI

Design, Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety

IF4.6

2021-05-2013

OAAI

Berberine Directly Targets the NEK7 Protein to Block the NEK7-NLRP3 Interaction and Exert Anti-inflammatory Activity

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-12-0159

PREAI

Structure-activity relationship and hypoglycemic activity of tricyclic matrines with advantage of treating diabetic nephropathy

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-09-018

PREAI

12N-Substituted Matrinol Derivatives Inhibited the Expression of Fibrogenic Genes via Repressing Integrin/FAK/PI3K/Akt Pathway in Hepatic Stellate Cells

IF4.6

2019-10-1711

OAAI

Synthesis and biological evaluation of 7-substituted cycloberberine derivatives as potent antibacterial agents against MRSA

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-04-0113

PREAI

Evolution and Antibacterial Evaluation of 8-Hydroxy-cycloberberine Derivatives as a Novel Family of Antibacterial Agents Against MRSA

IF4.6

2019-03-1112

OAAI

Synthesis and Biological Evaluation of Quinoline Derivatives as a Novel Class of Broad-Spectrum Antibacterial Agents

IF4.6

2019-02-0266

OAAI

Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2018-09-0129

PREAI

Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents

ACTA PHARMACEUTICA SINICA B

IF14.6

2018-07-0110

OAAI

Discovery and Development of 8-Substituted Cycloberberine Derivatives as Novel Antibacterial Agents against MRSA

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2018-04-1627

OAAI

Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2018-01-0117

PREAI

Synthesis and biological evaluation of 12-benzyl matrinic amide derivatives as a novel family of anti-HCV agents

CHINESE CHEMICAL LETTERS

IF8.9

2016-07-0120

PREAI